Fractionation of FRBA using a Sep-Pak Plus C18 cartridge resulted in fractions D–G, some of which possess the ability to reduce the inflammatory reaction of LPS-treated RAW 264.7 cells. (A) FRBD did not affect the expression of Il-1β, Il-6, or Tnf-α; (B) FRBE decreased the mRNA levels of Il-1β, Il-6, and Tnf-α; (C) FRBF reduced the expression of Il-1β and Il-6; (D) The FRBR treatment did not affect the mRNA levels of the pro-inflammatory cytokines in the LPS-activated RAW 264.7 cells. The data are represented as mean ± SE, n = 3. Significant differences between the LPS group and the other groups (Dunnet’s analysis, p < 0.05) are marked with asterisks (*).